Siegel RL, Giaquinto AN, Jemal A. Cancer statistics. CA Cancer J Clin. 2024;74(2024):12–49.
Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20:338–49.
Pividori M, Schoettler N, Nicolae DL, Ober C, Im HK. Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies. Lancet Respir Med. 2019;7:509–22.
Article PubMed PubMed Central Google Scholar
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48.
Article CAS PubMed Google Scholar
Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286–287:18–24.
Hu J, Yu W, Dai Y, Liu C, Wang Y, Wu Q. A deep neural network for gastric cancer prognosis prediction based on biological information pathways. J Oncol. 2022;2022:2965166.
Article PubMed PubMed Central Google Scholar
Stupack DG, Cheresh DA. A Bit-role for integrins in apoptosis. Nat Cell Biol. 2004;6:388–9.
Article CAS PubMed Google Scholar
Corpuz AD, Ramos JW, Matter ML. PTRH2: an adhesion regulated molecular switch at the nexus of life, death, and differentiation. Cell Death Discov. 2020;6:124.
Article CAS PubMed PubMed Central Google Scholar
Yao X, Gray S, Pham T, Delgardo M, Nguyen A, Do S, Ireland SK, Chen R, Abdel-Mageed AB, Biliran H. Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin. Biochem Biophys Res Commun. 2018;495:1240–8.
Article CAS PubMed Google Scholar
Yao X, Jennings S, Ireland SK, Pham T, Temple B, Davis M, Chen R, Davenport I, Biliran H. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells. PLoS ONE. 2014;9: e101564.
Article PubMed PubMed Central Google Scholar
Zheng J, Zhou J, Xie X, Xie B, Lin J, Xu Z, Zhang W. Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1. DNA Cell Biol. 2014;33:847–53.
Article CAS PubMed Google Scholar
Xiao Y, Yang Y, Wang J, Li W. Bit1 regulates cell migration and survival in oral squamous cell carcinoma. J Oral Maxillofac Surg. 2017:S0278239117303452.
Chen J, Liu H, Gao P, Hui Y, Yang Z, Zhang X, Xu P, Tian F, Fan T. Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus. Tumour Biol. 2017;39:1010428317708267.
Wang Z, Yin M, Wang R, Liu X, Yan D. Bit1 silencing enhances the proliferation, migration, and invasion of glioma cells through activation of the IL-6/STAT3 pathway. Onco Targets Ther. 2020;13:2469–81.
Article CAS PubMed PubMed Central Google Scholar
Fan T, Chen J, Zhang L, Gao P, Hui Y, Xu P, Zhang X, Liu H. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Mol Cancer. 2016;15:23.
Article PubMed PubMed Central Google Scholar
Nandakumar N, Gopinath P, Gopas J, Muraleedharan KM. Benzisothiazolone derivatives exhibit cytotoxicity in hodgkin’s lymphoma cells through NF-kappaB inhibition and are synergistic with doxorubicin and etoposide. Anticancer Agents Med Chem. 2020;20:715–23.
Article CAS PubMed Google Scholar
Covarrubias AA, Reyna-Jeldes M, Pedroso-Santana S, Marín S, Madero-Mendoza C, Demergasso C, Coddou C. Arsenic nanoparticles trigger apoptosis via anoikis induction in OECM-1 cells. In J Mol Sci. 2024;25:6723.
Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212–26.
Article CAS PubMed Google Scholar
Park E, Kim SW, Kim S, Kim HS, Lee JY, Kim YT, Cho NH. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix. Mod Pathol. 2021;34:637–46.
Article CAS PubMed Google Scholar
Abbas A, Jun P, Yuan JY, Sun L, Jiang J, Yuan S. Downregulation of GPR160 inhibits the progression of glioma through suppressing epithelial to mesenchymal transition (EMT) biomarkers. Basic Clin Pharmacol Toxicol. 2022;131:241–50.
Article CAS PubMed Google Scholar
Mahalanobish S, Saha S, Dutta S, Sil PC. Matrix metalloproteinase: an upcoming therapeutic approach for idiopathic pulmonary fibrosis. Pharmacol Res. 2020;152: 104591.
Article CAS PubMed Google Scholar
Piperigkou Z, Manou D, Karamanou K, Theocharis AD. Strategies to target matrix metalloproteinases as therapeutic approach in cancer. Methods Mol Biol. 2018;1731:325–48.
Article CAS PubMed Google Scholar
Turunen SP, Tatti-Bugaeva O, Lehti K. Membrane-type matrix metalloproteases as diverse effectors of cancer progression. Biochim Biophys Acta Mol Cell Res. 1864;2017:1974–88.
Uchihara T, Miyake K, Yonemura A, Komohara Y, Itoyama R, Koiwa M, Yasuda T, Arima K, Harada K, Eto K, Hayashi H, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Yashiro M, Masuda M, Ajani JA, Tan P, Baba H, Ishimoto T. Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 Induces FAK-YAP activation by stabilizing beta1 integrin, enhancing drug resistance. Cancer Res. 2020;80:3222–35.
Article CAS PubMed Google Scholar
Oria VO, Lopatta P, Schilling O. The pleiotropic roles of ADAM9 in the biology of solid tumors. Cell Mol Life Sci. 2018;75:2291–301.
Article CAS PubMed PubMed Central Google Scholar
Ma B, Ni N, Shao W, Xu J, Ji J, Luo M. Bit1 is involved in regulation between integrin and TGFbeta signaling in lens epithelial cells. Cell Cycle. 2022;21:2283–97.
Article CAS PubMed PubMed Central Google Scholar
Dattachoudhury S, Sharma R, Kumar A, Jaganathan BG. Sorafenib inhibits proliferation, migration and invasion of breast cancer cells. Oncology. 2020;98:478–86.
Article CAS PubMed Google Scholar
Kang ZR, Jiang S, Han JX, Gao Y, Xie Y, Chen J, Liu Q, Yu J, Zhao X, Hong J, Chen H, Chen YX, Chen H, Fang JY. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis. 2024;1870: 166941.
Article CAS PubMed Google Scholar
Lee SJ, Jeon SH, Cho S, Kim CM, Yoo JK, Oh SH, Kim JH, Yang YD, Kim JK. hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells. Biochim Biophys Acta Mol Basis Dis. 2024;1870: 167250.
Article CAS PubMed Google Scholar
Abadi AJ, Zarrabi A, Hashemi F, Zabolian A, Najafi M, Entezari M, Hushmandi K, Aref AR, Khan H, Makvandi P, Ashrafizaveh S, Farkhondeh T, Ashrafizadeh M, Samarghandian S, Hamblin MR. The role of SOX family transcription factors in gastric cancer. Int J Biol Macromol. 2021;180:608–24.
Article CAS PubMed Google Scholar
Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54.
Article PubMed PubMed Central Google Scholar
Yao X, Pham T, Temple B, Gray S, Cannon C, Chen R, Abdel-Mageed AB, Biliran H. The anoikis effector Bit1 inhibits EMT through attenuation of TLE1-mediated repression of E-cadherin in lung cancer cells. PLoS ONE. 2016;11: e0163228.
Comments (0)